نتائج البحث - Tony Pourmohamad
- يعرض 1 - 7 نتائج من 7
-
1
Cerebellar Arteriovenous Malformations حسب Ana Rodríguez-Hernández, Helen Kim, Tony Pourmohamad, William L. Young, Michael T. Lawton
منشور في 2012Artigo -
2
Brain Arteriovenous Malformation Multiplicity Predicts the Diagnosis of Hereditary Hemorrhagic Telangiectasia حسب Aditya Bharatha, Marie E. Faughnan, Helen Kim, Tony Pourmohamad, Timo Krings, Pınar Bayrak‐Toydemir, Ludmila Pawlikowska, Charles E. McCulloch, Michael T. Lawton, Christopher F. Dowd, William L. Young, Karel G. terBrugge
منشور في 2011Artigo -
3
Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: Gene–phenotype correlations حسب Takeo Nishida, Marie E. Faughnan, Timo Krings, Murali M. Chakinala, James R. Gossage, William L. Young, Helen Kim, Tony Pourmohamad, Katharine Henderson, Stacy D. Schrum, Melissa K. James, Nancy J. Quinnine, Aditya Bharatha, Karel G. terBrugge, Robert I. White
منشور في 2012Artigo -
4
Silent Intralesional Microhemorrhage as a Risk Factor for Brain Arteriovenous Malformation Rupture حسب Yi Guo, Tara A. Saunders, Hua Su, Helen Kim, Deniz Akkoc, David Saloner, Steven W. Hetts, Christopher P. Hess, Michael T. Lawton, Andrew W. Bollen, Tony Pourmohamad, Charles E. McCulloch, Tarık Tihan, William L. Young, Soonmee Cha, Christopher F. Dowd, Anne Fedoroff, Elizabeth C. Gardner, Van V. Halbach, Randall T. Higashida, Philippe Jolivalt, Brad Dispensa, Timothy M. Shepherd, Yuanli Zhao
منشور في 2012Artigo -
5
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors حسب Kyung Hae Jung, Patricia LoRusso, Howard A. Burris, Michael A. Gordon, Yung‐Jue Bang, Matthew D. Hellmann, Andrés Cervantes, María Ochoa de Olza, Aurélien Marabelle, F. Stephen Hodi, Myung‐Ju Ahn, Leisha A. Emens, Fabrice Barlési, Omid Hamid, Emiliano Calvo, David F. McDermott, Hatem Soliman, Ina Rhee, Ray Lin, Tony Pourmohamad, Julia Suchomel, Amy Lew Tsuhako, Kari M. Morrissey, Sami Mahrus, Roland Morley, Andrea Pirzkall, S. Lindsey Davis
منشور في 2019Artigo -
6
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors حسب Tae Won Kim, Howard A. Burris, Maria J. de Miguel, Michael J. Pishvaian, Yung‐Jue Bang, Michael S. Gordon, Ahmad Awada, D. Ross Camidge, F. Stephen Hodi, Grant A. McArthur, Wilson H. Miller, Andrés Cervantes, Laura Q.M. Chow, Alexander M. Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang‐Chiung Chen, Eric Stefanich, Tony Pourmohamad, Maria Inêz Padula Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L. Siu
منشور في 2022Artigo -
7
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors حسب Alessandra Castiglioni, Yagai Yang, Katherine Williams, Alvin Gogineni, Ryan S. Lane, Amber W. Wang, Justin A. Shyer, Zhe Zhang, Stephanie Mittman, Alan Gutierrez, Jillian L. Astarita, Minh Thai, Jeffrey Hung, Yeqing Angela Yang, Tony Pourmohamad, Patricia Himmels, Marco De Simone, Justin Elstrott, Aude-Hélène Capietto, Rafael Cubas, Zora Modrušan, Wendy Sandoval, James Ziai, Stephen E. Gould, Wenxian Fu, Yulei Wang, James T. Koerber, Shomyseh Sanjabi, Ira Mellman, Shannon J. Turley, Sören Müller
منشور في 2023Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Arteriovenous malformation
Angiography
Cerebral angiography
Intracranial Arteriovenous Malformations
Radiology
Surgery
Adverse effect
Asymptomatic
Biology
Cancer
Gastroenterology
Intracerebral hemorrhage
Multivariate analysis
Odds ratio
Oncology
Pathology
Pharmacokinetics
Receptor
Telangiectasia
Univariate analysis
ACVRL1
Agonist
Atezolizumab
Biochemistry
Blockade
CD34
CD8
Cancer research